Eribulin Mesylate Showed Treatment Activity in Advanced Breast Cancer
emaxhealth.com     May 17, 2008            

The investigational chemotherapeutic agent eribulin mesylate (E7389) demonstrated activity in a heavily pretreated population of women with locally advanced or metastatic breast cancer, according to results of a multi-center Phase II clinical trial. The study also suggests that eribulin mesylate... [read full story]                

Add a comment to the article
Type the code shown

View all news articles about:

- Related Topics

View other selected articles:

                   

Amgen says key bone drug trial meets goals

reuters.com     11 hrs ago   29 related          

By Deena Beasley LOS ANGELES (Reuters) - Amgen Inc said its experimental osteoporosis drug, denosumab, significantly reduced the risk of bone fracture in post-menopausal women in a large trial. Denosumab, a bioengineered...                

comments

                   

Cancer link fuels Vytorin debate

courierpostonline.com     11 hrs ago   3 related          

By STEVE STERNBERG USA TODAY • July 25, 2008 A study that unexpectedly linked the heart drug Vytorin to excess cancer deaths has provoked controversy among heart specialists worried that the drug's risks may outweigh its...                

comments

                   

Rimmer's drawings keep her going

nst.com.my     11 hrs ago          

KOTA KINABALU: Senyum sikit, she gently coaxes her 70-year-old subject, who flashes a toothy grin and starts giggling. The artist chuckles along with her, her eyes darting constantly from her subject to the portrait she is...                

comments

                   

Pets as teachers

thestar.com.my     10 hrs ago   1 related          

Don’t be surprised to see animals teaching students in this class. But the lecturers at Sunway University College’s School of Health and Natural Sciences do — from the pets that accompany them to work. In one class, the star...                

comments